RIGImmune Inc. Alternatives & Competitors
12 companies similar to RIGImmune Inc. — Targeted non-LNP Delivery of RNA Therapeutics
Companies similar to RIGImmune Inc.
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
MACROPHAGE PHARMA LIMITED
Empowering the immune system to combat cancer with precision-targeted therapies
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Vial
Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...
San Francisco, United Sta...
Rival Readout
Competing with RIGImmune Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ReCode Therapeutics
Powering the next wave of genetic medicines through superior delivery
United States
Orna Therapeutics
Wholly Owned Subsidiary of Eli Lilly and Company
Watertown, United States
Cardior Pharmaceuticals
Cardior develops RNA-based therapeutics designed to prevent, repair and reverse diseases o...
Germany
Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics...
London, United Kingdom
Ethris
Clinical stage biotech company focused on development of disruptive mRNA therapeutics for...
Planegg, Germany
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
About RIGImmune Inc.
RIGImmune Inc. is a promising player in the biopharmaceutical industry, with a sharp focus on pioneering RNA therapeutics to tackle serious respiratory diseases. Founded in 2020, this innovative company thrives on the cutting-edge discoveries of co-founders Drs.
Development of RNA therapeutics, Delivery Platform for RNA, Targeted Therapeutic Solutions for Respiratory Disorders
Patients with Respiratory Diseases, Healthcare Providers, Biopharmaceutical Partners, Scientific Researchers
RNA Therapeutics, Respiratory Diseases, SLR Technology, Nano-emulsion Delivery, Innate Immune Response, Cystic Fibrosis Treatment, Virus Diseases, Antitumor Immune Response, Biopharmaceutical Research, Novel Oligonucleotides, Targeted Drug Delivery, Non-LNP Delivery, Proprietary Technology, Yale University Collaboration, Immune-modulating Therapies
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around RIGImmune Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at RIGImmune Inc. on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
